novartis ag swiss drug maker novartis ag said it will sell the manufacturing facilities for multiple sclerosis drug betaseron to germanys bayer ag for &# million and plans to introduce its own version of the medicine in under a previous agreement novartis had produced the drug for bayer bayer will produce the drug for novartis when the swiss company starts selling its own branded version of betaseron the companies agreement is subject to approval from regulators novartis and bayer expect to complete the transaction in the third quarter 
